Cardiol Therapeutics Inc. Increase Decrease Through Exercise Of Warrants Equity
Cardiol Therapeutics Inc. (CRDL) reported Increase Decrease Through Exercise Of Warrants Equity of CAD 11.80 million for the 12-month period ending 2021-12-31, per its 20-F filed 2024-04-01.
Discontinued › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity · last filed 2024-04-01
| Period end | Increase Decrease Through Exercise Of Warrants Equity 12 month |
|---|---|
| 2021-12-31 | 11.80M CAD 20-F · filed 2024-04-01 |
| 2020-12-31 | 183.68K CAD 20-F · filed 2023-03-29 |